Radiation Oncology Treatment Planning Software Market Report 2026

The radiation oncology treatment planning software market size has grown strongly in recent years. It will grow from $2.51 billion in 2025 to $2.74 billion in 2026 at a compound annual growth rate (CAGR) of 9.1%. The growth in the historic period can be attributed to rising global cancer incidence, adoption of radiation therapy techniques, advancements in medical imaging technologies, demand for precise dose delivery, expansion of oncology treatment centers.

The radiation oncology treatment planning software market size is expected to see strong growth in the next few years. It will grow to $3.85 billion in 2030 at a compound annual growth rate (CAGR) of 8.9%. The growth in the forecast period can be attributed to growth of precision medicine adoption, integration of AI in clinical decision support, increasing investments in cancer care infrastructure, demand for reduced treatment side effects, expansion of advanced radiotherapy modalities. Major trends in the forecast period include AI-assisted treatment planning, 3D and adaptive radiation planning, integration with advanced imaging systems, personalized radiation therapy, workflow automation in oncology planning.

The rising prevalence of cancer is expected to drive growth in the radiation oncology treatment planning software market. This increase in cancer cases is attributed to factors such as an aging population, greater exposure to risk factors such as tobacco use, poor diets, and environmental pollutants, advancements in diagnostic technologies, and improved cancer survival rates. Radiation oncology treatment planning software leverages imaging data to accurately target tumors and protect healthy tissues. By creating detailed 3D models and optimizing dose and beam angles, it enhances treatment efficacy and reduces side effects. For example, in January 2024, the American Cancer Society reported 108,270 cases of skin cancer in the US, up 3.2% from the 104,930 cases in 2023, highlighting the growing demand for such technology.

Key players in the radiation oncology treatment planning software market are investing in advanced features such as centralized data management to improve tumor targeting precision and streamline workflow. Centralized data management consolidates patient information, treatment data, and imaging results into one accessible platform, enhancing workflow efficiency and decision-making. For instance, in June 2024, Accuray Incorporated, a US company specializing in radiation therapy, introduced the Accuray Precision Treatment Planning System (TPS). Approved by the Chinese National Medical Products Administration (NMPA), this system adapts treatment plans in real-time to accommodate changes in tumor size, shape, and location, thereby improving precision. It integrates with the Tomo C system, providing accurate dose control through helical imaging and radiation delivery while minimizing exposure to healthy tissues.

In April 2024, GE HealthCare Technologies, Inc., a US medical technology firm, acquired MIM Software Inc. The acquisition strengthens GE Healthcare's commitment to precision care by incorporating MIM’s technologies, which enable more personalized treatment plans and boost clinical workflow efficiency. MIM Software Inc., a provider of radiation oncology treatment planning software, will now be part of GE HealthCare, enhancing their automation capabilities and accelerating patient treatment.

Major companies operating in the radiation oncology treatment planning software market are Siemens Healthineers AG, Koninklijke Philips N.V., GE Healthcare Technologies Inc., Varian Medical Systems Inc., Elekta AB, Brainlab AG, IBA Worldwide SA, Canon Medical Systems Corporation, ViewRay Inc., RaySearch Laboratories AB, Vision RT Ltd., C‑RAD, MVision AI, DOSIsoft SA, Mirada Medical Ltd., Radformation Inc, Prowess Inc, Mevion Medical Systems, Oncology Systems Limited, Spectronic Medical AB, MeVis Medical Solutions AG, Lifeline Software Inc, Sun Nuclear Corporation, Shenzhen Mindray Bio‑Medical Electronics Co Ltd.

North America was the largest region in the radiation oncology treatment planning software market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the radiation oncology treatment planning software market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the radiation oncology treatment planning software market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Tariffs have affected the radiation oncology treatment planning software market by increasing costs of medical imaging equipment, computing hardware, and specialized treatment planning systems. These impacts are particularly evident in hospitals and cancer centers across asia pacific and europe that depend on imported medical technologies. Elevated costs have influenced procurement cycles and delayed technology upgrades. Software vendors are responding by optimizing solutions for existing hardware and promoting software-centric upgrades. In certain regions, tariffs are encouraging local development and deployment of oncology software solutions, strengthening domestic healthcare ecosystems.

The radiation oncology treatment planning software market research report is one of a series of new reports that provides radiation oncology treatment planning software market statistics, including radiation oncology treatment planning software industry global market size, regional shares, competitors with a radiation oncology treatment planning software market share, detailed radiation oncology treatment planning software market segments, market trends and opportunities, and any further data you may need to thrive in the radiation oncology treatment planning software industry. This radiation oncology treatment planning software market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Radiation oncology treatment planning software is an advanced tool designed to aid medical professionals in creating and refining radiation therapy plans for cancer patients. It calculates the precise dosage and delivery of radiation needed to target tumors while protecting surrounding healthy tissues. By using 3D models derived from patient imaging data, the software adjusts beam angles and intensities to improve the accuracy of treatment and reduce side effects.

The primary categories of radiation oncology treatment planning software include patient information systems and treatment planning systems. Patient information systems (PIS) are designed to manage and store patient data, streamline the handling of information, and enhance coordination among healthcare providers to deliver personalized treatment. These systems are utilized for various types of therapies, including stereotactic radiosurgery (SRS), three-dimensional conformal radiation therapy (3D CRT), brachytherapy, stereotactic body radiotherapy (SBRT), intensity-modulated radiation therapy (IMRT), and volumetric modulated arc therapy (VMAT). They are employed by a diverse range of users, such as hospitals, physician’s offices, research centers, government agencies, and cancer treatment centers.

The radiation oncology treatment planning software market consists of revenues earned by entities by providing services such as image integration, simulation and visualization, plan optimization, reporting and documentation, and patient data management. The market value includes the value of related goods sold by the service provider or included within the service offering. The radiation oncology treatment planning software market also includes sales of dose calculation engines, registration tools, and adaptive radiation therapy tools. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.